US2016194289A1PendingUtilityA1

Process for drying bendamustine hydrochloride monohydrate

Assignee: JOHNSON MATTHEY PLCPriority: Mar 14, 2013Filed: Mar 16, 2016Published: Jul 7, 2016
Est. expiryMar 14, 2033(~6.6 yrs left)· nominal 20-yr term from priority
C07D 235/16A61P 35/00
46
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Wet bendamustine hydrochloride monohydrate may be dried by a two stage process wherein rapid drying is first carried out to provide a partially dried product, which is then further dried using an inert gas of controlled relative humidity to yield dry bendamustine hydrochloride monohydrate.

Claims

exact text as granted — not AI-modified
1 .- 18 . (canceled) 
     
     
         19 . Dry bendamustine hydrochloride monohydrate produced by the method of claim  1 . 
     
     
         20 . Dry bendamustine hydrochloride monohydrate, containing less than 0.15%, as determined by HPLC area %, of monohydroxy-bendamustine. 
     
     
         21 . The dry bendamustine hydrochloride monohydrate of  claim 20 , containing less than 0.05%, as determined by HPLC area %, of monohydroxy-bendamustine. 
     
     
         22 . Dry bendamustine hydrochloride monohydrate, substantially free of any other physical form of bendamustine hydrochloride. 
     
     
         23 . Dry bendamustine hydrochloride monohydrate, substantially free of anhydrous bendamustine hydrochloride.

Join the waitlist — get patent alerts

Track US2016194289A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.